T wave oversensing in implantable cardioverter defibrillators

Journal of Interventional Cardiac Electrophysiology

Volumn 11, Issue 1, 2004, Pages 67-72

  Hsu, Steve S ^a   Mohib, Sayed ^a   Schroeder, Alice ^a   Deger, Florin T ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

implantable defibrillator; oversensing

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; DEFIBRILLATION; DEFIBRILLATOR; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PRIORITY JOURNAL; R WAVE; T WAVE;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ARTERIOSCLEROSIS; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EQUIPMENT FAILURE; HUMANS; MALE; SYNCOPE; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4043118422     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JICE.0000035932.25722.f1     Document Type: Article

References (17)

1. The Antiarrhythmic Versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-1583.
2. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:749-754.
3. Connolly S, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
4. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implantable defibrillator in patients with coronary artery disease at high risk of ventricular arrhythmias. N Engl J Med 1996;335:1933-1940.
5. Buxton A, Lee K, Fisher J, Josephson ME, Prystowsky EN, Hafley G, for the Multicenter Unsustained Tachycardia Trial (MUSTT) Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999;341:1882-1890.
6. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
7. Rosenquist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. Adverse effects with transvenous implantable cardioverter defibrillators: A prospective multicenter study. Circulation 1998;98:663-670.
8. Nanthakumar K, Paquette M, Newman D, Deno DC, Malden L, Gunderson B, Gilkerson J, Greene M, Heng D, Dorian P. Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators. Am Heart J 2000;139:797-803.
9. Peters RW, Cooklin M, Brockman R, Shorofsky SR, Gold MR. Inappropriate shocks from implanted cardioverter defibrillators caused by sensing of diaphragmatic myopotentials. J Interven Cardiac Electrophysiol 1998;12:367-370.
10. Niehaus M, Neuzner J, Vogt J, Korte T, Tebbenjohanns J. Adjustment of maximum automatic sensitivity (automatic gain control) reduces inappropriate therapies in patients with implantable cardioverter defibrillators. PACE 2002;25:151-155.
11. Deger FT, Khalighi K, Peters RW, Shorofsky SR, Gold MR. Sensing lead failure in implantable defibrillators: A comparison of two commonly used leads. J Cardiovasc Electrophysiol 2000;11:21-24.
12. Washizuka T, Chinushi M, Tagawa M, Kasai H, Watanabe H, Hosaka Y, Yamashita F, Furushima H, Abe A, Watanabe H, Hayashi J, Aizawa Y. Inappropriate discharges by fourth generation implantable cardioverter defibrillators in patients with ventricular arrhythmias. Jpn Circ J 2001;65:927-930.
13. Washizuka T, Chinushi M, Kasai H, Watanabe H, Tagawa M, Hosaka Y, Abe A, Aizawa Y. Inappropriate discharges from an intravenous implantable cardioverter defibrillator due to T wave oversensing. Jpn Circ J 2001;65:685-687.
14. Krishen A, Shepard RK, Leffler JA, Wood MA, Ellenbogen KA. Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemia. PACE 2001;24:1701-1703.
15. Brumwell DA, Kroll K, Lehmann MH. The amplifier: Sensing and depolarization. In: Kroll MW, Lehmann MH, eds., Implantable Cardioverter Defibrillator Therapy: The Engineering-Clinical Interface. Norwell, MA: Kluver Academic Publishers, 1996:275-302.
16. St Jude Medical. Atlas Model V-240, Model V-199 Implantable Cardioverter Defibrillator User's Manual, 2001:24.
17. Medtronic. MarquisTM DR 7274 Dual Chamber Implantable Cardioverter Defibrillator Reference Manual, 2002:40.